Advancements in AI-driven drug sensitivity testing research

Area of Science:

• Medical Microbiology
• Computational Biology
• Public Health

Background:

• Antimicrobial resistance (AMR) poses a significant global public health challenge.
• Empirical antibiotic therapy without timely Antimicrobial Susceptibility Testing (AST) can induce pathogen resistance.
• Rapid and accurate AST results are crucial for effective infection control and precision treatment.

Purpose of the Study:

• To provide a comprehensive overview of advancements in pathogen AST and resistance detection.
• To emphasize the prospective application of AI and ML in predicting drug sensitivity and pathogen resistance.
• To explore future directions in AST prediction for reducing antibiotic misuse and improving patient outcomes.

Main Methods:

• Review of recent advancements in AST methodologies.
• Exploration of artificial intelligence (AI), Machine Learning (ML), and Deep Learning (DL) applications in AST.
• Analysis of AI/ML capabilities in extracting information from imaging and laboratory data for resistance prediction.

Main Results:

• AI and ML technologies offer novel auxiliary diagnostic tools for AST.
• These technologies enable swift prediction of pathogen antibiotic resistance.
• AI/ML provide reliable evidence for judicious antibiotic selection.

Conclusions:

• AI and ML show significant promise in enhancing pathogen AST and resistance detection.
• Future applications of AI/ML in AST prediction can help reduce antibiotic misuse.
• These advancements are vital for addressing the global AMR crisis and improving patient care.